Mass vaccination in Norway could be delayed by up to 12 weeks due to Johnson & Johnson vaccine developments

Johnson & Johnson COVID-19 vaccine - JanssenPhoto: AP Photo / David Zalubowski

If neither the AstraZeneca nor the Johnson & Johnson vaccine is used in Norway, vaccination of people over the age of 18 could be delayed by up to twelve weeks.

“The delay will be significant if the AstraZeneca and Johnson & Johnson vaccines are not used, somewhere between eight and twelve weeks, we have estimated,” department director Line Vold at the FHI said at Tuesday’s press conference.

In June alone, Norway counted on just under one million doses of the Johnsen & Johnsen vaccines that were scheduled to arrive in Norway, Vold stated.

On Tuesday, Johnson & Johnson stated that the company is postponing the introduction of its coronavirus vaccine in Europe, pending investigations into reported blood clot cases.

Hundreds of thousands of doses of the vaccine were expected to be delivered to Europe in the coming weeks. The vaccine is administered in just one dose, and it should have been used to fully vaccinate 1.9 million Norwegians by August.

Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews

Do you have a news tip for Norway Today? We want to hear it. Get in touch at


Leave a comment

Your email address will not be published.